{"id":"https://openalex.org/W4396809668","doi":"https://doi.org/10.1136/jitc-2023-008417","title":"Stealth transgenes enable CAR-T cells to evade host immune responses","display_name":"Stealth transgenes enable CAR-T cells to evade host immune responses","publication_year":2024,"publication_date":"2024-05-01","ids":{"openalex":"https://openalex.org/W4396809668","doi":"https://doi.org/10.1136/jitc-2023-008417","pmid":"https://pubmed.ncbi.nlm.nih.gov/38724463","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11086422"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-008417","doi":"https://doi.org/10.1136/jitc-2023-008417","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-008417","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1136/jitc-2023-008417","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033773256","display_name":"Korneel Grauwet","orcid":"https://orcid.org/0009-0003-8077-2763","observed_orcids":["https://orcid.org/0009-0003-8077-2763"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Korneel Grauwet","raw_affiliation_strings":["Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030394595","display_name":"Trisha R. Berger","orcid":"https://orcid.org/0000-0003-3439-3239","observed_orcids":["https://orcid.org/0000-0003-3439-3239"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trisha Berger","raw_affiliation_strings":["Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0000-0003-3439-3239","affiliations":[{"raw_affiliation_string":"Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041791638","display_name":"Michael C. Kann","orcid":"https://orcid.org/0000-0002-5917-0296","observed_orcids":["https://orcid.org/0000-0002-5917-0296"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael C Kann","raw_affiliation_strings":["Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014226056","display_name":"Harrison Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harrison Silva","raw_affiliation_strings":["Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062214590","display_name":"Rebecca C. Larson","orcid":"https://orcid.org/0000-0003-0174-061X","observed_orcids":["https://orcid.org/0000-0003-0174-061X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Larson","raw_affiliation_strings":["Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0000-0003-0174-061X","affiliations":[{"raw_affiliation_string":"Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012987786","display_name":"Mark B. Leick","orcid":"https://orcid.org/0000-0003-3111-0221","observed_orcids":["https://orcid.org/0000-0003-3111-0221"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark B Leick","raw_affiliation_strings":["Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA","Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA","Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083811774","display_name":"Stefanie R. Bailey","orcid":"https://orcid.org/0000-0002-1175-521X","observed_orcids":["https://orcid.org/0000-0002-1175-521X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefanie R Bailey","raw_affiliation_strings":["Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073324722","display_name":"Amanda A. Bouffard","orcid":"https://orcid.org/0009-0003-1501-4384","observed_orcids":["https://orcid.org/0009-0003-1501-4384"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda A Bouffard","raw_affiliation_strings":["Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018418926","display_name":"David G. Millar","orcid":"https://orcid.org/0000-0002-0104-9303","observed_orcids":["https://orcid.org/0000-0002-0104-9303"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Millar","raw_affiliation_strings":["Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009794322","display_name":"Kathleen Gallagher","orcid":"https://orcid.org/0009-0004-4818-2082","observed_orcids":["https://orcid.org/0009-0004-4818-2082"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen Gallagher","raw_affiliation_strings":["Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA","Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089990813","display_name":"Cameron John Turtle","orcid":"https://orcid.org/0000-0002-4722-4461","observed_orcids":["https://orcid.org/0000-0002-4722-4461"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cameron J Turtle","raw_affiliation_strings":["Department of Medicine, University of Washington, Seattle, Washington, USA","Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Washington, Seattle, Washington, USA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, Washington, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064556004","display_name":"Matthew J. Frigault","orcid":"https://orcid.org/0000-0002-6774-5694","observed_orcids":["https://orcid.org/0000-0002-6774-5694"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew J Frigault","raw_affiliation_strings":["Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA","Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA","Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0000-0002-6774-5694","affiliations":[{"raw_affiliation_string":"Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029763484","display_name":"Marcela Valderrama Maus","orcid":"https://orcid.org/0000-0002-7578-0393","observed_orcids":["https://orcid.org/0000-0002-7578-0393"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marcela V Maus","raw_affiliation_strings":["Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA","Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA","Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0000-0002-7578-0393","affiliations":[{"raw_affiliation_string":"Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5029763484"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":3.7005,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.95356668,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"12","issue":"5","first_page":"e008417","last_page":"e008417"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8539999723434448},{"id":"https://openalex.org/keywords/tapis","display_name":"TAPI","score":0.6690000295639038},{"id":"https://openalex.org/keywords/epstein-barr-virus","display_name":"Epstein-Barr virus","score":0.902999997138977},{"id":"https://openalex.org/keywords/allogeneic-car-t-cells","display_name":"allogeneic CAR T cells","score":0.7879999876022339},{"id":"https://openalex.org/keywords/autologous-car-t-cells","display_name":"autologous CAR T cells","score":0.8399999737739563},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.4779999852180481},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.710822582244873},{"id":"https://openalex.org/C2775890610","wikidata":"https://www.wikidata.org/wiki/Q14914108","display_name":"CIITA","level":5,"score":0.6765393018722534},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5144110321998596},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5133499503135681},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.46196550130844116},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4586515426635742},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4377009868621826},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43215441703796387},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.42717432975769043},{"id":"https://openalex.org/C83464605","wikidata":"https://www.wikidata.org/wiki/Q575296","display_name":"Antigen presentation","level":4,"score":0.42620033025741577},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.418249249458313},{"id":"https://openalex.org/C2778814158","wikidata":"https://www.wikidata.org/wiki/Q959350","display_name":"MHC class II","level":4,"score":0.24062922596931458}],"mesh":[{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019076","descriptor_name":"Transgenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1136/jitc-2023-008417","doi":"https://doi.org/10.1136/jitc-2023-008417","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-008417","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11086422","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11086422","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11086422/pdf/jitc-2023-008417.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Immunother Cancer","raw_type":"Text"},{"id":"pmid:38724463","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38724463","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for immunotherapy of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:ecfec6545a5648c1bf0005393d1e6f09","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ecfec6545a5648c1bf0005393d1e6f09","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 12, Iss 5 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-008417","doi":"https://doi.org/10.1136/jitc-2023-008417","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-008417","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3847398283","display_name":"Training in Transplantation Biology","funder_award_id":"T32AI007529","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G6365229912","display_name":"Training in Pharmacological Sciences","funder_award_id":"T32GM007306","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G9000874717","display_name":"Molecular Immunology and Tumor Biology","funder_award_id":"T32CA009216","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000877653","display_name":"Novel CAR T cell engineering strategies for effective eradication of solid and liquid tumors","funder_award_id":"R01CA238268","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4396809668.pdf","grobid_xml":"https://content.openalex.org/works/W4396809668.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W1829817483","https://openalex.org/W1963549388","https://openalex.org/W1989550920","https://openalex.org/W1993511176","https://openalex.org/W2002694645","https://openalex.org/W2014273057","https://openalex.org/W2038426832","https://openalex.org/W2056662191","https://openalex.org/W2073300038","https://openalex.org/W2074130081","https://openalex.org/W2086928462","https://openalex.org/W2087857484","https://openalex.org/W2111504710","https://openalex.org/W2145985838","https://openalex.org/W2161888051","https://openalex.org/W2342423058","https://openalex.org/W2597129987","https://openalex.org/W2773804840","https://openalex.org/W2787301955","https://openalex.org/W2802912386","https://openalex.org/W2971361007","https://openalex.org/W2972019268","https://openalex.org/W2985370419","https://openalex.org/W2988100850","https://openalex.org/W2991627551","https://openalex.org/W2996818159","https://openalex.org/W2998345757","https://openalex.org/W3017464623","https://openalex.org/W3028983520","https://openalex.org/W3041276616","https://openalex.org/W3088453061","https://openalex.org/W3094079847","https://openalex.org/W3120017373","https://openalex.org/W3120439501","https://openalex.org/W3132274017","https://openalex.org/W3186077712","https://openalex.org/W3198558595","https://openalex.org/W3200033310","https://openalex.org/W3213256696","https://openalex.org/W4200014243","https://openalex.org/W4200201081","https://openalex.org/W4210271098","https://openalex.org/W4220766750","https://openalex.org/W4223582500"],"related_works":["https://openalex.org/W4388047665","https://openalex.org/W4310106425","https://openalex.org/W4310099653","https://openalex.org/W3215314073","https://openalex.org/W3214368184","https://openalex.org/W4308375586","https://openalex.org/W4282966131","https://openalex.org/W4388048225","https://openalex.org/W4417004974","https://openalex.org/W3094192101"],"abstract_inverted_index":{"BACKGROUND:":[0],"Adoptive":[1],"cell":[2,10,26,80,216,283,292,348],"therapy,":[3,11],"such":[4],"as":[5,41],"chimeric":[6],"antigen":[7,107,132],"receptor":[8],"(CAR)-T":[9],"has":[12],"improved":[13],"patient":[14,185,331],"outcomes":[15],"for":[16,141],"hematological":[17],"malignancies.":[18],"Currently,":[19],"four":[20],"of":[21,62,69,85,100,113,116,124,128,173,200,324,337],"the":[22,29,42,58,83,110,117,125,201,264,307,316,322,345],"six":[23],"FDA-approved":[24],"CAR-T":[25,64,71,79,226,256,291,341],"products":[27],"use":[28],"FMC63-based":[30,339],"\u03b1CD19":[31,224,255,340],"single-chain":[32],"variable":[33],"fragment,":[34],"derived":[35],"from":[36,249],"a":[37,94,138],"murine":[38],"monoclonal":[39],"antibody,":[40],"extracellular":[43],"binding":[44],"domain.":[45],"Clinical":[46],"studies":[47],"demonstrate":[48],"that":[49,259,315,334],"patients":[50,250,286],"develop":[51],"humoral":[52],"and":[53,82,109,160,165,175,187,205,212,221,232,241,269,294,326],"cellular":[54,328],"immune":[55],"responses":[56,284,349],"to":[57,76,97],"non-self":[59],"CAR":[60,260],"components":[61],"autologous":[63,182,254,270,304,325,338],"cells":[65,103,227,248,257,262,342],"or":[66],"donor-specific":[67],"antigens":[68],"allogeneic":[70,190,194,268,327],"cells,":[72],"which":[73,273],"is":[74],"thought":[75],"potentially":[77],"limit":[78],"persistence":[81],"success":[84],"repeated":[86,335],"dosing.":[87],"METHODS:":[88],"In":[89],"this":[90,295],"study,":[91],"we":[92,280],"implemented":[93],"one-shot":[95],"approach":[96],"prevent":[98],"rejection":[99],"engineered":[101],"T":[102,247,261,347],"by":[104,156],"simultaneously":[105],"reducing":[106,215],"presentation":[108],"surface":[111,217],"expression":[112,123],"both":[114],"Classes":[115],"major":[118],"histocompatibility":[119],"complex":[120],"(MHC)":[121],"via":[122],"viral":[126],"inhibitors":[127],"transporter":[129],"associated":[130],"with":[131,137,246,253,303],"processing":[133],"(TAPi)":[134],"in":[135,154,168,170,180,188,223,230,233,277,285,300,350],"combination":[136,151,199],"transgene":[139],"coding":[140],"shRNA":[142,207],"targeting":[143,208],"class":[144],"II":[145,222],"MHC":[146,218],"transactivator":[147],"(CIITA).":[148],"The":[149,198],"optimal":[150],"was":[152,166,178,210,274,297],"screened":[153],"vitro":[155,231,301],"flow":[157],"cytometric":[158],"analysis":[159],"mixed":[161],"lymphocyte":[162,238],"reaction":[163,239],"assays":[164,240,244],"validated":[167,276],"vivo":[169,234],"mouse":[171,195],"models":[172],"leukemia":[174],"lymphoma.":[176],"Functionality":[177],"assessed":[179],"an":[181,189,193,206],"setting":[183,191],"using":[184,192],"samples":[186],"model.":[196],"RESULTS:":[197],"Epstein-Barr":[202],"virus":[203],"TAPi":[204],"CIITA":[209],"efficient":[211],"effective":[213],"at":[214],"classes":[219],"I":[220],"'stealth'":[225],"while":[228],"retaining":[229],"antitumor":[235],"functionality.":[236],"Mixed":[237],"IFN\u03b3":[242],"ELISpot":[243],"performed":[245],"previously":[251],"treated":[252],"confirm":[258],"expressing":[263],"stealth":[265,308,318],"transgenes":[266,319],"evade":[267],"anti-CAR":[271,346],"responses,":[272],"further":[275],"vivo.":[278],"Importantly,":[279],"noted":[281],"anti-CAR-T":[282],"who":[287],"had":[288],"received":[289],"multiple":[290],"infusions,":[293],"response":[296],"reduced":[298],"on":[299],"restimulation":[302],"CARs":[305],"containing":[306],"transgenes.":[309],"CONCLUSIONS:":[310],"Together,":[311],"these":[312,351],"data":[313,332],"suggest":[314],"proposed":[317],"may":[320],"reduce":[321],"immunogenicity":[323],"therapeutics.":[329],"Moreover,":[330],"indicate":[333],"doses":[336],"significantly":[343],"increased":[344],"patients.":[352]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-05-11T00:00:00"}